Drug development against metastasis-related genes and their pathways: A rationale for cancer therapy
Authors:
- Wen LiuWLWen Liu
- Kounosuke WatabeKWKounosuke Watabe
- 1 December 2008
- journal article
- review article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
- Vol. 1786 (2) , 87-104
Abstract
No abstract availableKeywords
This publication has 279 references indexed in Scilit:
- Metastasis: recent discoveries and novel treatment strategiesThe Lancet, 2007
- R-Etodolac decreases β-catenin levels along with survival and proliferation of hepatoma cellsJournal of Hepatology, 2007
- Transforming growth factor-β in cancer and metastasisCancer and Metastasis Reviews, 2006
- Cancer spread and micrometastasis development: Quantitative approaches for in vivo modelsBioEssays, 2002
- Dissemination and growth of cancer cells in metastatic sitesNature Reviews Cancer, 2002
- Inhibition Mechanism of Cytokine Activity of Human Autocrine Motility Factor Examined by Crystal Structure Analyses and Site-directed Mutagenesis StudiesJournal of Molecular Biology, 2002
- All-trans retinoic acid and interferon-α in the treatment of a patient with resistant metastatic osteosarcomaCancer, 2000
- The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous PolyposisNew England Journal of Medicine, 2000
- The potential roles of nm23 in cancer metastasis and cellular differentiationEuropean Journal of Cancer, 1995
- Deferoxamine followed by cyclophosphamide, etoposide, carboplatin, thiotepa, induction regimen in advanced neuroblastoma: Preliminary resultsEuropean Journal of Cancer, 1995